Evidence map›Paper›PMID 11401966›Full record

ArticleInfection and immunity2001

Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis.

J L Dahl, J Wei, J W Moulder, S Laal, R L Friedman

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Virulence-Associated Secretion inFrontiers in immunology · 2022
    Review
  4. Host Cell Targets of Released Lipid and Secreted Protein Effectors ofFrontiers in cellular and infection microbiology · 2020
    Review
  5. The Macrophage Response toFrontiers in cellular and infection microbiology · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Structure of Mycobacterium smegmatis Eis in complex with paromomycin.Acta crystallographica. Section F, Structural biology communications · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  17. Article
  18. Article
  19. Unusual regioversatility of acetyltransferase Eis, a cause of drug resistance in XDR-TB.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

J L DahlDepartment of Microbiology and Immunology, University of Arizona, Tucson 85724, USA.
J Wei
J W Moulder
S Laal
R L Friedman
University of Arizona · USNYU Langone Health · US

Funding

M. tuberculosis survival in MacrophagesR01AI045537 · NIAID · UNIVERSITY OF ARIZONA · PI FRIEDMAN, RICHARD LEE · 2001 to 2003
$947k
M TUBERCULOSIS SURVIVAL IN MACROPHAGESR21AI045537 · NIAID · UNIVERSITY OF ARIZONA · PI FRIEDMAN, RICHARD LEE · 1999 to 1999
–
NIAID NIH HHS AI45537NIAID NIH HHS AI45537-01A2NIAID NIH HHS R01 AI045537NIAID NIH HHS R21 AI045537
6 · The paper itself

Abstract

Mycobacterium tuberculosis is a facultative intracellular pathogen that has evolved the ability to survive and multiply within human macrophages. It is not clear how M. tuberculosis avoids the destructive action of macrophages, but this ability is fundamental in the pathogenicity of tuberculosis. A gene previously identified in M. tuberculosis, designated eis, was found to enhance intracellular survival of Mycobacterium smegmatis in the human macrophage-like cell line U-937 (J. Wei et al., J. Bacteriol. 182:377-384, 2000). When eis was introduced into M. smegmatis on a multicopy vector, sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed the appearance of a unique 42-kDa protein band corresponding to the predicted molecular weight of the eis gene product. This band was electroeluted from the gel with a purity of >90% and subjected to N-terminal amino acid sequencing, which demonstrated that the 42-kDa band was indeed the protein product of eis. The Eis protein produced by M. tuberculosis H37Ra had an identical N-terminal amino acid sequence. A synthetic polypeptide corresponding to a carboxyl-terminal region of the deduced eis protein sequence was used to generate affinity-purified rabbit polyclonal antibodies that reacted with the 42-kDa protein in Western blot analysis. Hydropathy profile analysis showed the Eis protein to be predominantly hydrophilic with a potential hydrophobic amino terminus. Phase separation of M. tuberculosis H37Ra lysates by the nonionic detergent Triton X-114 revealed the Eis protein in both the aqueous and detergent phases. After fractionation of M. tuberculosis by differential centrifugation, Eis protein appeared mainly in the cytoplasmic fraction but also in the membrane, cell wall, and culture supernatant fractions as well. Forty percent of the sera from pulmonary tuberculosis patients tested for anti-Eis antibody gave positive reactions in Western blot analysis. Although the function of Eis remains unknown, evidence presented here suggests it associates with the cell surface and is released into the culture medium. It is produced during human tuberculosis infection and therefore may be an important M. tuberculosis immunogen.

Indexed as

Antigens, BacterialMycobacterium tuberculosisAcetyltransferasesAmino Acid SequenceAntibodies, BacterialBacterial ProteinsBase SequenceCell FractionationCentrifugationCulture MediaDetergentsDNA, BacterialGlycoproteinsHumansIntracellular FluidMolecular Sequence DataAcetyltransferasesAntibodies, BacterialAntigens, BacterialBacterial ProteinsCulture MediaDetergentsDNA, BacterialEis protein, Mycobacterium tuberculosisGlycoproteinsNonidet P-40OctoxynolPolyethylene Glycols

Identifiers

PMID11401966
PMCPMC98499
OpenAlexW2165503654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.